Drugs / ATIGLIFLOZIN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00361738 | Jul 2006 → Jan 2008 | type 2 diabetes mellitus | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATIGLIFLOZIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314949 ↗ |
| Known as | AVE2268 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00361738 ↗ |
| Modality | Small molecule | — CHEMBL5314949 ↗ |